LENZ Therapeutics, Inc. (NASDAQ:LENZ) Q3 2024 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to the LENZ Therapeutics' Third Quarter 2024 Conference Call. At this time, all participants are in a listen-only mode.
Lenz Therapeutics Inc. (LENZ)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Nantahala Capital Management Wilmot B. Harkey And Daniel Mack | 0 | $0 | -100% | 0% |
| 2. | Samsara BioCapital Srini Akkaraju And Michael Dybbs | 0 | $0 | -100% | 0% |
| 3. | Prosight Capital Lawrence Hawkins | 0 | $0 | -100% | 0% |
| 4. | Millennium Management Israel Englander | 0 | $0 | -100% | 0% |
| 5. | Citadel Investment Group Ken Griffin | 0 | $0 | -100% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $15.68 | 3,188 | Officer | 3,188 | 2024-05-14 | Filing | |
| $15.99 | 31,332 | Director | 525,565 | 2024-05-13 | Filing | |
| $15.03 | 64,971 | 694,755 | 2024-03-21 | Filing | ||
| $15.03 | 933,038 | 3,319,339 | 2024-03-21 | Filing | ||
| $4.08 | 350,000 | Large Shareholder | 8,459,314 | 2022-04-12 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 251,431.28,571,429 | $4,611,249 | 0% | |
| 2. | 203,711.42,857,143 | $3,736,068 | 0% | |
| 3. | 100,438.71,428,571 | $1,842,046 | 0.11% | |
| 4. | 79,307.571,428,571 | $1,454,675 | 0% | |
| 5. | 63,916.571,428,571 | $1,172,230 | 0.88% |
News See All
LENZ Therapeutics, Inc. (NASDAQ:LENZ) Q2 2024 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the LENZ Therapeutics Second Quarter 2024 Conference Call. At this time, all participants are in a listen-only mode.
LENZ Therapeutics, Inc. (NASDAQ:LENZ) Q1 2024 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. At this time, I would like to welcome everyone to LENZ Therapeutics First Quarter 2024 Financial Results and Business Update.
Billionaire Hedge Funds
